Therefore, a significantly reduced level of CD9 and CD81 expression, rather than an ambiguous increase in CD63 expression, can be used as an indicator of oral cancer, even in the early stages of the disease. This evidence concerns the gene CD81 and lip and oral cavity carcinoma.